Med-Tech Start-Ups Using Revenue To Gain Funding

Wall Street Journal | By Timothy Hay

As tough economic times put the clamp on start-up companies and the investors who back them, exotic financing tools—especially those that don’t dilute the value of a company—are beginning to look increasingly attractive.